News about " kidney transplantation"

TolerogenixX Secures EU Orphan Drug Designation for MIC-Lx in Living-Donor Kidney Transplantation

TolerogenixX Secures EU Orphan Drug Designation for MIC-Lx in Living-Donor Kidney Transplantation

European Commission grants orphan status to Tolerogenix’s personalized cell therapy following EMA recommendation, strengthening its regulatory pathway alongside recent PRIME designation.

Kidney Transplantation | 14/07/2026 | By News Bureau 100

Hansa Biopharma's Imlifidase BLA Accepted by US FDA for Priority Review

Hansa Biopharma's Imlifidase BLA Accepted by US FDA for Priority Review

FDA accepts Hansa Biopharma’s BLA for imlifidase, supported by strong Phase III ConfIdeS data demonstrating significant kidney function improvement in highly sensitized transplant patients.

Kidney Transplantation | 20/02/2026 | By News Bureau 413

European Commission Approves Sobi's Aspaveli for Rare Kidney Diseases C3G and IC-MPGN

European Commission Approves Sobi's Aspaveli for Rare Kidney Diseases C3G and IC-MPGN

The European Commission has approved Sobi’s Aspaveli for adolescents and adults with rare kidney diseases C3G and IC-MPGN, marking the first approved therapy for these conditions.

Kidney Transplantation | 19/01/2026 | By News Bureau 267


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members